Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 3c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 3c, Revenues Beat

Cumberland Pharmaceuticals Reports Second Quarter 2018 Financial Results

August 14, 2018 4:05 PM EDT

NASHVILLE, Tenn., Aug. 14, 2018 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, and oncology supportive care today announced second quarter 2018 financial results and Company update. Cumberland has a portfolio of seven U.S. Food and Drug Administration (FDA) approved brands. Net revenues for the quarter were $10.2 million, an increase of 17% over the prior year period and an 18% increase over the first quarter of this year.  At the end of the second quarter, Cumberland had $90 million in total assets, including approximately $51 million in cash and marketable securities.

... More